| Loi Dai Vo, MD | |
|
1017 W Fertitta Blvd, Leesville, LA 71446-4646 | |
| (337) 239-2606 | |
| (337) 238-5748 |
| Full Name | Loi Dai Vo |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1017 W Fertitta Blvd, Leesville, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215911029 | NPI | - | NPPES |
| 1663328 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 11402R (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Loi Dai Vo, MD 1017 W Fertitta Blvd, Leesville, LA 71446-4646 Ph: (337) 239-2606 | Loi Dai Vo, MD 1017 W Fertitta Blvd, Leesville, LA 71446-4646 Ph: (337) 239-2606 |
News Archive
Around-the-clock care from senior physicians helped reduce major complications in cardiac surgery patients as compared to receiving care from resident physicians, according to a new University of Alberta study.
Viruses that can seek and destroy food poisoning bugs in the gut are being investigated by researchers at The University of Nottingham, thanks to a prestigious new grant.
In a demonstration of the power of green chemistry, scientists are reporting development of a new and more efficient process for making one of the most costly and widely used medications for severe mental illness.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the granting by the U.S. Patent and Trademark Office (USPTO) of U.S. Patent 7,728,131 for oncology drug candidate bafetinib, encompassing claims related to bafetinib's pharmaceutical compound and composition in all indications, as well as for use in methods for treating acute and chronic myelogenous leukemia and acute lymphoblastic leukemia.
› Verified 7 days ago
Jocelyne Afif Saikali, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 W Arkansas St, Leesville, LA 71446 Phone: 337-239-7227 Fax: 337-238-4299 | |
Mr. Kanchan Prasad Upadhyay, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 931 Verone Ter, Leesville, LA 71446 Phone: 337-238-3475 Fax: 337-238-3617 | |
Mohammad Mustafa Saidan, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1020 Fertitta Blvd, Byrd Regional Hospital,, Leesville, LA 71446 Phone: 337-239-5119 | |
Dr. Thomas E Dobbins, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 506 S 6th St, Leesville, LA 71446 Phone: 337-239-0989 | |
Hanna G Lubbos, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 W Arkansas St, Leesville, LA 71446 Phone: 337-239-7227 Fax: 337-238-4299 | |
Dr. Jose Mathew, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 Port Arthur Ter, Leesville, LA 71446 Phone: 337-392-2211 Fax: 337-392-2210 |